Skip to main content
. Author manuscript; available in PMC: 2024 Jun 13.
Published in final edited form as: J Clin Virol. 2017 Mar 23;91:90–94. doi: 10.1016/j.jcv.2017.03.012

Table 2.

Summary of INSTI reactivity using HIV-1 plasma specimens from the STOP study.

INSTI results
Results of previous testing of ARC-positive plasma specimens Total positive negative
MS-PL negative/SP-FS negative 51 7 44
MS-PL negative/SP-FS positive 2 0 2
MS-PL negative/SP-FS not available 21 8 13
Total 74 15 59
MS-PL indeterminate/SP-FS negative 9 6 3
MS-PL indeterminate/SP-FS positive 1 1 0
MS-PL indeterminate/SP-FS not available 1 1 0
Total 11 8 3
MS-PL positive/SP-FS negative 9 9 0
MS-PL positive/SP-FS positive 174 174 0
MS-PL positive/SP-FS not available 20 20 0
Total 203 203 0

ARC: Abbott Architect; MS: Bio-Rad Multispot; SP: Clearview Stat-Pak rapid test; PL: plasma; FS: fingerstick whole blood; MS-PL-negative and –indeterminate specimens all tested positive with NAT.